A Study In Adult Healthy Volunteers To Asses Once Daily (QD) Dosing With The Selected Age-Appropriate Modified Release (MR) Formulations
Clinical trial NCT04338711 · COMPLETED
Trial details
- NCT number
- NCT04338711
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-17
- Primary completion
- 2020-09-15
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.